post hoc

9 similar searches for post hoc

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

More than 10.000 documents for post hoc

- New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia[R] (certolizumab pegol) at Week 12 Was Predictive of Week 52 Response.
* At Week 12, the majority of patients treated with Cimzia([R]) (certolizumab pegol) plus methotrexate had good/moderate RAPID3 or EULAR responses *...
- Business Wire
- November 07, 2011
- Schumacher v. Amalgamated Leasing, Inc., (Ohio 2004)
Civ. R. 12(B)(6): motion to dismiss-federal pre-emption-Art. VI, cl. 2, U.S. Constitution-presumption against pre-emption-Airline Deregulation Act of 1978-49 U.S.C. 41713: states may not enact or enforce law related to a price, route, or service of an air carrier-Whistleblower Protection Program: 49 U.S.C. 42121-"related to" defined as connected with or in reference to-"services" defined to include bargained for aspects of airline industry with its customers-post hoc reporting of a safety violation is not related to the services of an airline-R.C. 4113.52 not pre-empted by federal law
- Ohio Supreme Court
- In a Post-Hoc Analysis, JANUVIA[R] (sitagliptin), Merck's Diabetes Medicine, Compared with a Sulfonylurea (Glipizide) on Composite Endpoint of Lower Blood Sugar, No Hypoglycemia and No Weight Gain.
New Data Presented at the American Diabetes Association 70(th) Annual Scientific Sessions WHITEHOUSE STATION, N.J. -- In a new post-hoc analysis pre...
- Business Wire
- June 28, 2010

- Merck's ROTATEQ(R) Reduced Hospitalizations and Emergency Department Visits Due to G9P1A(8) Rotavirus by 100 Percent as Shown by Post-hoc Analysis of Data.
WHITEHOUSE STATION, N.J. -- The prescribing information for Merck & Co., Inc.'s ROTATEQ([R]) (rotavirus vaccine, live, oral pentavalent), the only vac...
- Business Wire
- December 03, 2007
- Tapentadol Data to Be Presented at 2010 American Pain Society Annual Meeting
RARITAN, N.J., May 3 /PRNewswire/ -- Data on tapentadol for the relief of acute and chronic pain, as well as patient and prescriber perceptions of oxycodone immediate-release treatments, will be presented at the 29th Annual Scientific Meeting of the American Pain Society (APS) May 6-8, 2010. Four of the 12 poster presentations will review analyses of tapentadol data, including a post-hoc analysis of a Phase 3 tolerability study on NUCYNTA(R) (tapentadol) tablets for acute pain in elderly patients (greater than or equal to 65 years of age), a population that may be more susceptible to opioid-related gastrointestinal side effects. Three of the presentations will review post-hoc analyses of data from a Phase 3, 1-year safety study on the investigational tapentadol extended release (ER) tab...
- U.S. Newswire
- May 03, 2010
- Post-Hoc Sub-Analysis from LIFE Trial Presented at American Heart Association Meeting.
Business Editors/Health & Pharmaceutical Writers CHICAGO--(BUSINESS WIRE)--Nov. 19, 2002 Merck & Co., Inc. (NYSE:MRK) COZAAR Significantly Reduc...
- Business Wire
- November 19, 2002
- Resistance to Ethically Suspicious Parody Video On Youtube: A Test of Inoculation Theory
Having observed the proliferation of corporate stealth campaigns employing parody videos on YouTube, we attempted to examine the effectiveness of refutational preemption in providing viewers with ability to detect unduly manipulative intent and in conferring viewer resistance to the influence of the campaign. We also compared the relative efficacy of the inoculation pretreatment to post-hoc refutation. Results showed that subjects who received a preemptive inoculation message were better able to detect unduly manipulative intent in a parody video, were more resistant to altering their original attitudes toward the issue, and demonstrated less favorable attitudes toward the sponsor of the parody video than did their counterparts in the control group.
- Journalism and Mass Communication Quarterly
- Vol. 84 Nbr. 4, December 2007
- TYSABRI(R) Demonstrates Sustained Improvement in Functional Outcomes in Multiple Sclerosis Patients According to New Post-Hoc Analysis.
-- TYSABRI is the Only Marketed MS Treatment to Show Both Significant Slowing in Disability Progression and Sustained Improvement in Physical Disabili...
- Business Wire
- September 19, 2008
- Impaired and Incapacitated Rape Victims: Assault Characteristics and Post-Assault Experiences
Alcohol is the most common "rape drug," with up to two-thirds of victims consuming alcohol prior to the assault. Surprisingly, little research has examined the assault and postassault experiences of victims who were impaired or incapacitated as a result of substance use, including alcohol, during a rape. Thus, the current study evaluated the assault and postassault experiences of a sample of 340 nonimpaired, impaired, and incapacitated college rape victims. Results supported that these three groups differed in several assault characteristics, including threats by the assailant, resistance by the victim, and relationship with the assailant. In addition, impairment and incapacitation were associated with several postassault factors, including self-blame, stigma, and problematic alcohol us...
- Violence and Victims
- Vol. 24 Nbr. 4, July 2009
- Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS).
Initial Analysis of the Full Study Cohort Showed Treatment Did Not Demonstrate Significant Effect on Primary Endpoint of Accumulated Delay to Disabili...
- Business Wire
- February 27, 2007